Kelonia Therapeutics
Maggie Lau is a Senior Associate Scientist II specializing in Analytical Development at Kelonia Therapeutics since January 2022, having previously held the titles of Senior Associate Scientist and Associate Scientist II within the same department. Prior to that, Maggie worked at Affinivax Inc. from December 2019 to December 2021, where roles included Research Associate II and Research Associate I in Bioanalytical Assay. Maggie's career began at Massachusetts Eye and Ear as a Research Technician from November 2017 to December 2019. An alumnus of the University of Massachusetts Amherst, Maggie earned a Bachelor of Science degree in Microbiology, General in 2017.
This person is not in any offices
Kelonia Therapeutics
1 followers
Kelona is revolutionizing gene delivery to expand the impact of genetic medicines. Their goal is to develop a new wave of accessible genetic medicines that will transform the lives of patients suffering from a broad range of conditions.